Intensification of Care to Improve Adherence to Anti-hypertensives
NCT ID: NCT01331369
Last Updated: 2017-04-11
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
243 participants
INTERVENTIONAL
2010-11-30
2012-04-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Telehealth & Remote Measurement Technologies to Improve Medication Adherence in Hypertension
NCT01439256
Adherence to Antihypertensive Therapy--Data Analyses
NCT00006552
Clinician Counseling and Cultural Competency to Improve Hypertension Control and Therapy Adherence
NCT00201149
To Assess Adherence to the Treatment and Quality of Life in Patients With Hypertension
NCT00944489
Evaluation of a Transmedial Psychoeducational Program to Improve Pharmacological Adherence
NCT03924115
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
HEALTH_SERVICES_RESEARCH
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Control
Usual care. It means routine medical care that include free demand consultation and free medicines.
Usual Care
Usual care provided (medical and/or nurse consultation and medicines)
Intervention
Intensification of care. Besides routine medical care that include free demand consultation and free medicines, subjects were invited to have 6 structured medical encounters based on a social-psychological approach. Doctors must follow a protocol to conduct the encounter that have around 30 minutes each.
Intensification of Care
Usual provided care plus social-psychological intervention: 6 consultation with doctors and 9 with community health workers, both oriented by protocol.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Intensification of Care
Usual provided care plus social-psychological intervention: 6 consultation with doctors and 9 with community health workers, both oriented by protocol.
Usual Care
Usual care provided (medical and/or nurse consultation and medicines)
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* pregnants
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Fundacao de Apoio a Pesquisa de Santa Catarina
UNKNOWN
Universidade de Blumenau
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Ernani Tiaraju de Santa Helena
Professor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Ernani S Helena, PhD
Role: PRINCIPAL_INVESTIGATOR
Regional University of Blumenau
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Family Health Units - Unique Health System
Blumenau, Santa Catarina, Brazil
Countries
Review the countries where the study has at least one active or historical site.
Related Links
Access external resources that provide additional context or updates about the study.
Research Group of Pharmacoepidemiology
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
FURB 2010/01
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.